Related Experiment Video
Updated: Apr 21, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Acute kidney injury: cell cycle arrest biomarkers win race for AKI diagnosis
Zoltán H Endre1, John W Pickering2
1Department of Nephrology, Prince of Wales Hospital and Clinical School, University of New South Wales, High Street, Randwick, Sydney, NSW 2031, Australia.
Abstract:
FDA approval of the first device to use novel biomarkers of kidney damage to assess risk of acute kidney injury (AKI) potentially brings forward diagnosis of moderate-to-severe AKI to a time frame that could enable early intervention. Although the device awaits greater scrutiny, its approval marks the beginning of a new era.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care

